Arduino has recently introduced a new Bluetooth-based provisioning flow on the Arduino Cloud, starting with the UNO R4 WiFi ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. It’s no secret that we love Amazon. New here?

Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...